PMCTPharmaCountry
    Startseite
ARCALIS, Inc. logo
ARCALIS, Inc.

ARCALIS, Inc.

Lohnhersteller (CMO) · ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)Flag of JPJapan
1.3K
27
17
3.5(72)

Über das Unternehmen

  • Firmenname (rechtlich): ARCALIS, Inc.
  • Registrierungsland: Japan
  • Adresse: 226-39, Wakashiba,,, Kashiwa Shi
  • Anzahl der Mitarbeiter: 100 - 249
Beschreibung:

A CDMO specializing in mRNA medicines and vaccines, founded by Axcelead (Japan's first drug discovery platform) and Arcturus Therapeutics (a US mRNA company). In 2023, ARCALIS opened a GMP mRNA drug substance facility in Japan, and in 2024 achieved the world's first commercial production of a self-amplifying mRNA COVID-19 vaccine, supporting clients from early research through commercial production across rare diseases, oncology, regenerative medicine and genome editing.

Geschäftsaktivitäten

ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)

Lohnhersteller (CMO)
Hauptprodukte/-dienstleistungen

Unsere Produkte & Dienstleistungen

Sell · Contract & Outsourcing Services
ARCALIS, Inc. sell "Non-GMP mRNA Development & CMC Services"
ARCALIS, Inc.
ARCALIS, Inc.
Flag of JP Japan

ARCALIS, Inc. sell "Non-GMP mRNA Development & CMC Services"

Non-GMP mRNA Development & CMC Services

Service Provider: ARCALIS, Inc., Japan

Details ansehen
Sell · Contract & Outsourcing Services
ARCALIS, Inc. sell "GMP Manufacturing Services for mRNA and LNP"
ARCALIS, Inc.
ARCALIS, Inc.
Flag of JP Japan

ARCALIS, Inc. sell "GMP Manufacturing Services for mRNA and LNP"

GMP Manufacturing Services for mRNA and LNP

Service Provider: ARCALIS, Inc., Japan

Details ansehen

Certifications

GMP

Filter:
Sortieren nach:

    Keine Kommentare verfügbar.